Dr. Nabil A Phillips, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1100 N Tustin Ave, Suite A, Santa Ana, CA 92705 Phone: 714-542-9100 Fax: 714-542-9105 |
Dr. Edward Robert Alexson, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1401 N Tustin Ave, Suite 220, Santa Ana, CA 92705 Phone: 714-835-4800 Fax: 714-835-1900 |
News Archive
DNA breaks from radiation, toxic chemicals, or other environmental causes occur routinely in cells and, unless promptly and properly repaired, can lead to cancer-causing mutations.
A recent study by researchers at the University of British Columbia (B.C.) shows that the benefits of continuing the COVID-19 vaccine of front-line workers with the AstraZeneca vaccine outweigh the increased risk of prothrombotic thrombocytopenia.
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
Synergetics USA, Inc. today announced its preliminary results for the third fiscal quarter ended April 30, 2010 related to the allocation of proceeds from the settlement, license and supply agreement with Alcon Laboratories, Inc. and the expected gain from the sale of the OmniĀ® product line to Stryker Corporation.
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
› Verified 6 days ago